Monoamine oxidase inhibition dramatically increases the motivation to self-administer nicotine in rats
- PMID: 16177026
- PMCID: PMC6725504
- DOI: 10.1523/JNEUROSCI.2139-05.2005
Monoamine oxidase inhibition dramatically increases the motivation to self-administer nicotine in rats
Abstract
Nicotine is the major neuroactive compound of tobacco, which has, by itself, weak reinforcing properties. It is known that levels of the enzymes monoamine oxidase A (MAO-A) and MAO-B are reduced in the platelets and brains of smokers and that substances, other than nicotine, present in tobacco smoke have MAO-inhibitory activities. Here, we report that inhibition of MAO dramatically and specifically increases the motivation to self-administer nicotine in rats. These effects were more prominent in rats selected for high responsiveness to novelty than in rats with low responsiveness to novelty. The results suggest that the inhibition of MAO activity by compounds present in tobacco smoke may combine with nicotine to produce the intense reinforcing properties of cigarette smoking that lead to addiction.
Figures







Similar articles
-
Effects of Monoamine Oxidase Inhibition on the Reinforcing Properties of Low-Dose Nicotine.Neuropsychopharmacology. 2016 Aug;41(9):2335-43. doi: 10.1038/npp.2016.36. Epub 2016 Mar 9. Neuropsychopharmacology. 2016. PMID: 26955970 Free PMC article.
-
Monoamine oxidase A rather than monoamine oxidase B inhibition increases nicotine reinforcement in rats.Eur J Neurosci. 2006 Dec;24(12):3532-40. doi: 10.1111/j.1460-9568.2006.05217.x. Eur J Neurosci. 2006. PMID: 17229101
-
The effect of mixed tobacco monoamine oxidase inhibitors in animal models relevant to tobacco dependence.Psychopharmacology (Berl). 2025 Mar;242(3):617-628. doi: 10.1007/s00213-024-06712-8. Epub 2024 Nov 18. Psychopharmacology (Berl). 2025. PMID: 39556208
-
A review of monoamine oxidase (MAO) inhibitors in tobacco or tobacco smoke.Neurotoxicology. 2022 Dec;93:163-172. doi: 10.1016/j.neuro.2022.09.008. Epub 2022 Sep 23. Neurotoxicology. 2022. PMID: 36155069 Review.
-
Monoamine oxidase inhibition in cigarette smokers: From preclinical studies to tobacco product regulation.Front Neurosci. 2022 Aug 16;16:886496. doi: 10.3389/fnins.2022.886496. eCollection 2022. Front Neurosci. 2022. PMID: 36051642 Free PMC article. Review.
Cited by
-
Self-administration of nicotine and cigarette smoke extract in adolescent and adult rats.Neuropharmacology. 2016 Oct;109:247-253. doi: 10.1016/j.neuropharm.2016.06.026. Epub 2016 Jun 23. Neuropharmacology. 2016. PMID: 27346207 Free PMC article.
-
Markov model- Quantifying outlook towards success of tobacco cessation counseling.J Family Med Prim Care. 2022 Aug;11(8):4263-4266. doi: 10.4103/jfmpc.jfmpc_2096_21. Epub 2022 Aug 30. J Family Med Prim Care. 2022. PMID: 36352913 Free PMC article. Review.
-
Study protocol: evaluation of the addictive potential of e-cigarettes (EVAPE): neurobiological, sociological, and epidemiological perspectives.BMC Psychol. 2021 Nov 18;9(1):181. doi: 10.1186/s40359-021-00682-8. BMC Psychol. 2021. PMID: 34794514 Free PMC article.
-
In Vitro and Ex Vivo Approaches to Evaluate Next-Generation Tobacco and Non-Tobacco Products on Human Blood Platelets.Appl In Vitro Toxicol. 2017 Mar 1;3(1):110-120. doi: 10.1089/aivt.2016.0034. Appl In Vitro Toxicol. 2017. PMID: 28337466 Free PMC article.
-
Effects of nicotine in experimental animals and humans: an update on addictive properties.Handb Exp Pharmacol. 2009;(192):335-67. doi: 10.1007/978-3-540-69248-5_12. Handb Exp Pharmacol. 2009. PMID: 19184655 Free PMC article. Review.
References
-
- Baker GB, Wong JT, Yeung JM, Coutts RT (1991) Effects of the antidepressant phenelzine on brain levels of gamma-aminobutyric acid (GABA). J Affect Disord 21: 207–211. - PubMed
-
- Berlin I, Anthenelli RM (2001) Monoamine oxidases and tobacco smoking. J Int Neuropsychopharmacol 4: 33–42. - PubMed
-
- Berlin I, Said S, Spreux-Varoquaux O, Olivares R, Launay JM, Puech AJ (1995) Monoamine oxidase A and B activities in heavy smokers. Biol Psychiatry 38: 756–761. - PubMed
-
- Blier P, De Montigny C, Azzaro AJ (1986) Modification of serotonergic and noradrenergic neurotransmissions by repeated administration of monoamine oxidase inhibitors: electrophysiological studies in the rat central nervous system. J Pharmacol Exp Ther 237: 987–994. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources